Objectives: (1a) Compare change in health-related quality of life (HRQoL) from pre- to post-diagnosis of kidney cancer (KC) in older KC patients and matched noncancer subjects (controls). (1b) Identify factors associated with HRQoL changes in older KC patients. (2) Evaluate the association between HRQoL and overall survival in older KC patients. (3) Determine one-year and five-year total healthcare costs and resource use associated with renal cell carcinoma (RCC) in the US.
Methods: Three longitudinal, retrospective cohort studies were conducted. The 1998–2013 Surveillance, Epidemiology, and End Results (SEER) linked with Medicare Health Outcomes Survey was used for objectives 1a, 1b, and 2 and 2006–2014 SEER-Medicare claims was for the last objective. Statistical analyses included generalized linear mixed-effects models (objective 1a), ordinary least square regression models (objective 1b), Cox proportional hazard models (objective 2), and linear models using inverse probability weighting accounting for patient censoring (objective 3).
Results: The impact of KC was prominent on older patients’ physical health, social functioning, and vitality. Older patients with advance-stage KC, belonging to lower socio-economic group, or those with a history of stroke or chronic arthritis/sciatica were at a greater risk of deteriorations in HRQoL. Clinically meaningful reductions in patients’ HRQoL from pre- to post-diagnosis of KC was significantly associated with their long-term overall survival. Lastly, we observed that the healthcare sector spent, on average, 3–7 times and 1–5 times more healthcare dollars for patients with RCC compared to controls, for one-year and five-year after RCC diagnosis, respectively.
Conclusions: Burden of living with KC is substantial on older Americans with KC as well as the US healthcare system. The findings may help clinicians set patient’s expectations about their physical health changes after KC diagnosis and its treatment and become more aware of the risk factors associated with HRQoL deterioration. Given the rising interest in utilizing patient-reported outcomes in clinical oncology settings, HRQoL monitoring should be added to the long-term care plan for KC patients. Estimated economic costs of RCC from this study can be useful to healthcare policymakers and payers in planning resource allocations and determining future research priorities in this patient population.
|Commitee:||Kent, Erin E., McAdam-Marx, Carrie, Kamel, Mohamed, Ounpraseuth, Songthip T., Tilford, J. Mick|
|School:||University of Arkansas for Medical Sciences|
|School Location:||United States -- Arkansas|
|Source:||DAI-B 81/5(E), Dissertation Abstracts International|
|Subjects:||Pharmaceutical sciences, Health sciences|
|Keywords:||Clinical outcomes, Economic outcomes, Health outcomes, Kidney cancer, Older Americans, Renal cell carcinoma|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be